First City Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

First City Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10	Closed	-$197	–	551
2016 Q1	$197	Hold	10	–	–	﹤0.01%	652
2015 Q4	$190	Hold	10	–	–	﹤0.01%	652
2015 Q3	$191	Hold	10	–	–	﹤0.01%	621
2015 Q2	$464	Hold	10	–	–	﹤0.01%	588
2015 Q1	$437	Hold	10	–	–	﹤0.01%	566
2014 Q4	$347	Hold	10	–	–	﹤0.01%	594
2014 Q3	$419	Hold	10	–	–	﹤0.01%	601
2014 Q2	$586	Hold	10	–	–	﹤0.01%	613
2014 Q1	$630	Buy	+10	New	+$663	﹤0.01%	605

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

First City Capital Management's ARNA Position: Q2 2016 in Review

First City Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2016, closing a stake of 10 shares — an estimated $197 sold.

First City Capital Management first reported a position in ARNA in Q1 2014 and held it in 9 quarters. The position peaked at $630 in Q1 2014. 119 funds tracked by Wall St. Rank hold ARNA as of Q2 2016.

First City Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
First City Capital Management sold 10 Arena Pharmaceuticals Inc shares in Q2 2016, an estimated $197.
First City Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 9 quarters.
First City Capital Management's Arena Pharmaceuticals Inc position peaked at $630 in Q1 2014.
119 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.